Showing results (121-130 of 186) with videos related to
Sort By:
Pageof 19
Circulation|April 1, 1983
The diagnosis of acute, recurrent, deep-vein thrombosis: a diagnostic challengeR D Hull, C J Carter, R M Jay, et al.Blood|February 1, 1982
The diagnostic value of the fibrinogen/fibrin fragment E antigen assay in clinically suspected deep vein thrombosisA Zielinsky, J Hirsh, G Straumanis, et al.Annals of Internal Medicine|September 1, 1992
A low-molecular-weight heparinoid compared with unfractionated heparin in the prevention of deep vein thrombosis in patients with acute ischemic stroke. A randomized, double-blind studyA G Turpie, M Gent, R Côte, et al.Circulation|July 1, 1997
Comparison of low-molecular-weight heparin with unfractionated heparin acutely and with placebo for 6 weeks in the management of unstable coronary artery disease. Fragmin in unstable coronary artery disease study (FRIC)W Klein, A Buchwald, S E Hillis, et al.Circulation|May 20, 1998
Economic assessment of low-molecular-weight heparin (enoxaparin) versus unfractionated heparin in acute coronary syndrome patients: results from the ESSENCE randomized trial. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q wave Coronary Events [unstable angina or non-Q-wave myocardial infarction]D B Mark, P A Cowper, S D Berkowitz, et al.BMJ (Clinical Research Ed.)|February 6, 1998
Compression ultrasonography for diagnostic management of patients with clinically suspected deep vein thrombosis: prospective cohort studyA Cogo, A W Lensing, M M Koopman, et al.Circulation|September 1, 1983
Clinical pharmacology of propafenoneS J Connolly, R E Kates, C S Lebsack, et al.The American Journal of Cardiology|February 1, 1984
Clinical efficacy and electrophysiology of imipramine for ventricular tachycardiaS J Connolly, L B Mitchell, C D Swerdlow, et al.The American Journal of Cardiology|December 15, 1996
Comparison of mortality from acute myocardial infarction between 1979 and 1992 in a geographically defined stable populationC A Le Feuvre, S J Connolly, J A Cairns, et al.Journal of the American College of Cardiology|August 1, 1991
Canadian Atrial Fibrillation Anticoagulation (CAFA) StudyS J Connolly, A Laupacis, M Gent, et al.Pageof 19